Endothelial cell microRNA expression in human late-onset Fuchs' dystrophy

Area of Science:

• Ophthalmology
• Molecular Biology
• Genetics

Background:

• MicroRNAs (miRNAs) are crucial regulators of gene expression.
• Dysregulation of miRNAs is implicated in various diseases, including corneal pathologies.
• Fuchs' endothelial corneal dystrophy (FECD) is a progressive corneal disease affecting the endothelium.

Purpose of the Study:

• To investigate differential miRNA expression in human FECD compared to normal corneal endothelium.
• To identify specific miRNAs involved in the pathogenesis of FECD.
• To establish the first miRNA profile for FECD.

Main Methods:

• Comparative miRNA expression profiling using OpenArray plate technology on endothelial samples from FECD patients and normal donors.
• Validation of differentially expressed miRNAs via stem-loop RT qPCR assays.
• Assessment of miRNA target gene expression using qPCR and tissue microarray (TMA) immunolabeling.

Main Results:

• Downregulation of 87 miRNAs observed in FECD endothelium compared to normal controls (>3-fold change, P < 0.01).
• Significant decrease in DICER1 expression, a key enzyme in miRNA biogenesis, in FECD samples.
• Repression of miR-29 family members (miR-29a-3p, miR-29b-2-5p, miR-29c-5p) correlated with increased expression of their targets, collagen I and collagen IV.
• Histological evidence of subendothelial collagen I and IV deposition and increased laminin in FECD samples.

Conclusions:

• This study presents the first comprehensive miRNA profile in FECD.
• Widespread miRNA downregulation is a key feature of FECD pathogenesis.
• Reduced expression of miR-29 family members may drive the accumulation of extracellular matrix in FECD, contributing to disease progression.